A3 Adenosine receptors mediate oligodendrocyte death and ischemic damage to optic nerve

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Adenosine receptor activation influences myelination and apoptosis in neurodegenerative diseases.
• Oligodendrocytes are crucial for myelin sheath formation and maintenance in the central nervous system.

Purpose of the Study:

• To investigate the impact of adenosine receptor activation on oligodendrocyte viability in the rat optic nerve.
• To explore the role of A3 receptors in oligodendrocyte death and optic nerve injury.

Main Methods:

• Primary oligodendrocyte cultures and ex vivo optic nerve explants were used.
• Selective A3 receptor agonists and antagonists were applied.
• Assays included cell viability, oxidative stress, mitochondrial membrane potential, and caspase activation.
• In vivo optic nerve ischemia models were employed.

Main Results:

• Selective A3 receptor activation induced concentration-dependent apoptotic and necrotic oligodendrocyte death.
• A3 receptor activation led to oxidative stress and mitochondrial dysfunction.
• Caspase-dependent and independent pathways mediated A3 receptor-induced apoptosis.
• Ex vivo and in vivo studies showed A3 receptor activation caused oligodendrocyte damage, myelin loss, and functional deficits.
• A3 receptor antagonists and caffeine protected against these effects.
• Blocking A3 receptors attenuated ischemia-induced optic nerve injury.

Conclusions:

• Adenosine, via A3 receptor activation, triggers oligodendrocyte death and myelin damage.
• This mechanism contributes to ischemic injury in the optic nerve and white matter.
• Targeting A3 receptors may offer a therapeutic strategy for white matter disorders.